Science
Mechanism of Action
This oil primarily acts through its dominant component, 1,8-cineole, which modulates immune responses to inflammation and infection. It actively diminishes redness and calms the skin by engaging anti-inflammatory pathways. Its antimicrobial efficacy is achieved by disrupting bacterial cell walls, increasing permeability, and triggering the release of essential cellular constituents. Additionally, it functions as a potent antioxidant, shielding the skin from environmental damage and potentially mitigating UVB-induced collagen degradation. The oil further supports skin barrier integrity by enhancing ceramide content and possesses inherent purifying and antiseptic qualities.
Research
Clinical Evidence
Medium confidence0.5-2%
Key findings
- 01 A clinical study involving 25 subjects demonstrated no irritation or sensitization when eucalyptus oil was applied topically at 10%.
- 02 For general topical use, a dilution of 1-2% is recommended for safe and effective application, while facial application suggests a 0.5-1% dilution to prevent irritation.
- 03 Eucalyptus oil exhibited significant antibacterial activity against Staphylococcus aureus at a 25% concentration (species not specified for this specific finding).
- 04 Higher concentrations (50-100%) of eucalyptus oil were successfully used in human facial demodicosis treatment, resulting in complete cure.
Transparency
Dusting Analysis
The available research data does not provide sufficient information to determine if EUCALYPTUS PARVULA LEAF OIL is commonly subjected to 'dusting' practices or to establish specific dusting thresholds or red flag percentages.
The Formula
Formulation
Stability
As an essential oil, EUCALYPTUS PARVULA LEAF OIL is inherently oil-soluble and necessitates dilution with a carrier oil for safe topical application. In water-based formulations, the incorporation of emulsifiers, such as polysorbate 80, is essential to ensure proper dispersion. No specific optimal pH range for its stability was identified in the provided research.
Conflicts
- Pure, undiluted application on skin (risk of irritation, burning, and potential nervous system issues)
- Use by individuals with known allergies to tea tree oil (due to shared chemical compounds)
- Application during pregnancy or breastfeeding periods
- Inclusion in products intended for infants and children (due to potential adverse neurological effects like seizures)
- High concentrations on sensitive skin types
Safety
Safety Profile
Specific CIR or SCCS safety assessments for EUCALYPTUS PARVULA LEAF OIL are not readily available. While general eucalyptus oil is recognized as Generally Recognized as Safe (GRAS) by the FDA for food use and is permitted in some Over-the-Counter (OTC) drug products for colds and coughs at 1.2-1.3% (referring to *Eucalyptus globulus* oil), pure, undiluted application can cause severe skin irritation, burning, and potential nervous system complications. Patch-testing data indicates a 0.24-1.5% prevalence of positive reactions for allergic contact dermatitis with 2% eucalyptus oil. It is strongly not recommended for use by pregnant or nursing individuals, or for children, due to potential adverse neurological effects.
Your Skin
Skin Compatibility
Our Assessment
Verdict
EUCALYPTUS PARVULA LEAF OIL is a valuable ingredient for its robust anti-inflammatory, antimicrobial, and antioxidant properties, provided it is precisely formulated and used at recommended low concentrations to ensure skin compatibility and safety.
Related
Similar Ingredients
Finding similar ingredients…